Subscribe to stay informed!
While biotech is a tough line of work that has a historically high percentage of companies whose stock trades at or below their cash value…
Berwyn-based Virpax Pharmaceuticals has decided to take the over-the-counter route toward regulatory approval for Epoladerm, its experimental pain treatment for osteoarthritis, writes…
West Chester-based Virpax Pharmaceuticals has signed a deal with London’s Nanomerics for exclusive, North American rights to the life sciences company’s experimental…
Before we send you to this site, please subscribe to our daily newsletter.